Some of these cookies are strictly necessary for operation of this site. Other, non-essential cookies are used for measuring website performance (which is all aggregated and anonymised) and may share this information with Google. To consent to non-essential cookies, click "Accept all non-essential cookies".
Mercia invested into Medherant at seed stage and has supported the company through its growth. Along with Medherant's management team, Peter Dines, COO and Head of Life Sciences & Biosciences at Mercia, looks back on the company's growth and discusses the exciting opportunities in this market and industry.